Mohamed A Elkoushy1, Mazen Jundi2, Terence T N Lee2, Sero Andonian2. 1. Division of Urology, Department of Surgery, McGill University Health Centre, McGill University, Montreal, QC; ; Department of Urology, Suez Canal University, Ismailia, Egypt. 2. Division of Urology, Department of Surgery, McGill University Health Centre, McGill University, Montreal, QC;
Abstract
INTRODUCTION: We assessed abnormalities in bone mineral density (BMD) and the risk of hip and major osteoporotic fractures in urolithiasis patients with vitamin D inadequacy (VDI) followed at a tertiary stone centre. METHODS: Stone-free patients with VDI were invited to undergo dual-energy x-ray absorptiometry (DXA) scans to assess for BMD abnormalities at the femoral neck and lumbar spine. The World Health Organization's validated Fracture Risk Assessment Tool (FRAX) was used to calculate the risk of hip and major osteoporotic fractures within 10 years. Patients with primary hyperparathyroidism or hypercalcemia were excluded. RESULTS: In total, 50 consecutive patients were included between June 2011 and August 2012, including 26 (52%) males. The median age was 51 years and the median 25-hydroxyl vitamin D (25[OH] D) was 18.8 ng/mL. Thirty patients (60%) had abnormal T-scores on DXA studies. This decreased to 22 (44%) when age-matched Z-scores were used; 36% had osteopenia and 8% had osteoporosis. Femoral neck and lumbar spines were affected in 24% and 32% of patients, respectively. Recurrent stone-formers had significantly lower BMD when compared with first-time stone formers. Median serum 25(OH)D was comparable between patients with normal and abnormal DXA scans (18.6 vs. 18.8 ng/mL; p = 0.91). Five patients (10%) were at high risk (≥3%) of hip fractures within 10 years. CONCLUSION: A high prevalence of abnormal DXA scans was found in urolithiasis patients with VDI, including 5 patients (10%) at high risk of hip fractures. Future studies need to assess the economic impact of obtaining DXA scans on urolithiasis patients with VDI, especially in recurrent stone-formers.
INTRODUCTION: We assessed abnormalities in bone mineral density (BMD) and the risk of hip and major osteoporotic fractures in urolithiasispatients with vitamin D inadequacy (VDI) followed at a tertiary stone centre. METHODS: Stone-free patients with VDI were invited to undergo dual-energy x-ray absorptiometry (DXA) scans to assess for BMD abnormalities at the femoral neck and lumbar spine. The World Health Organization's validated Fracture Risk Assessment Tool (FRAX) was used to calculate the risk of hip and major osteoporotic fractures within 10 years. Patients with primary hyperparathyroidism or hypercalcemia were excluded. RESULTS: In total, 50 consecutive patients were included between June 2011 and August 2012, including 26 (52%) males. The median age was 51 years and the median 25-hydroxylvitamin D (25[OH] D) was 18.8 ng/mL. Thirty patients (60%) had abnormal T-scores on DXA studies. This decreased to 22 (44%) when age-matched Z-scores were used; 36% had osteopenia and 8% had osteoporosis. Femoral neck and lumbar spines were affected in 24% and 32% of patients, respectively. Recurrent stone-formers had significantly lower BMD when compared with first-time stone formers. Median serum 25(OH)D was comparable between patients with normal and abnormal DXA scans (18.6 vs. 18.8 ng/mL; p = 0.91). Five patients (10%) were at high risk (≥3%) of hip fractures within 10 years. CONCLUSION: A high prevalence of abnormal DXA scans was found in urolithiasispatients with VDI, including 5 patients (10%) at high risk of hip fractures. Future studies need to assess the economic impact of obtaining DXA scans on urolithiasispatients with VDI, especially in recurrent stone-formers.
Authors: Natalia O Kuchuk; Natasja M van Schoor; Saskia M Pluijm; Arkadi Chines; Paul Lips Journal: J Bone Miner Res Date: 2009-04 Impact factor: 6.741
Authors: Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger Journal: Arch Intern Med Date: 2004-05-24
Authors: Michael Soueidan; Susan J Bartlett; Yasser A Noureldin; Ross E Andersen; Sero Andonian Journal: Can Urol Assoc J Date: 2015 Jul-Aug Impact factor: 1.862
Authors: María Sierra Girón-Prieto; María Del Carmen Cano-García; Miguel Ángel Arrabal-Polo; Antonio Poyatos-Andujar; Miguel Quesada-Charneco; Tomás de Haro-Muñoz; Salvador Arias-Santiago; Miguel Arrabal-Martín Journal: Int Urol Nephrol Date: 2016-04-19 Impact factor: 2.370